Healthcare and Policy: Preserving Neuromodulation

4:00 PM - 5:30 PM Saturday, January 19

Healthcare economics and policy are playing a larger role in the access to neuromodulation-based treatments. This session will define the current status of healthcare and the challenges facing the field of neuromodulation. In addition, the influence of neuromodulation on economic outcomes will be explored.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Describe the current status of healthcare policy and the associated implications for the field of neuromodulation.
  • Define the role of neuromodulation in influencing pain related healthcare costs.
  • Identify the cost-effectiveness of intrathecal therapy.
  • Explain the economic factors related to the delivery of healthcare for chronic low back pain.

NANS Advocacy and Policy Committee: The Current State of Healthcare and Challenges for Neuromodulation

David Kloth, MD

Economic Factors Related to the Delivery of Healthcare for Chronic Low Back Pain

Richard B. North, MD

Economic Decision Making for Procedures with High Fixed Expenses: Deep Brain Stimulation Cost

Donald M. Whiting, MD, MS, FACS

Long-Term Cost Utility of Spinal Cord Stimulation in Patients with Failed Back Surgery Syndrome

Nandan Lad, MD PhD

Faculty subject to change.